(1)
TO INCREASE THE EFFECTIVENESS OF TREATMENT OF PURULENT-INFLAMMATORY DISEASES OF THE FACIAL JAW AREA WITH MODERN BINDING AGENTS. ibmscr 2024, 4 (2), 91-95.